How Many Units Is 2.5 mg of Tirzepatide?

If you are asking how many "units" equal 2.5 mg of tirzepatide, the honest answer is the one nobody puts on a label: it depends on the concentration of the specific vial in your hand, and there is no universal number. The FDA-approved brands — Zepbound and Mounjaro — are never dosed in units at all. They come as single-dose pens or vials that deliver a fixed milligram amount per 0.5 mL, so a person on brand tirzepatide never has to convert anything¹². The "units" question only comes up with compounded tirzepatide drawn from a multi-dose vial into an insulin syringe — and that is exactly where the math gets dangerous.

This page explains why, shows the arithmetic for the concentrations compounding pharmacies commonly use, and is blunt about the risk: people have given themselves ten-fold overdoses doing this conversion wrong³.

First: the brand product is not measured in units

Tirzepatide is a prescription-only medicine, and the two FDA-approved brands are not sold by the unit. Zepbound (for obesity and obstructive sleep apnea) and Mounjaro (for type 2 diabetes) are dispensed as single-dose pens or single-dose vials, each delivering a set strength — 2.5, 5, 7.5, 10, 12.5, or 15 mg — in 0.5 mL¹². You inject the whole device. There is no syringe to fill to a line, no "units" to count, and no conversion to make. The entire titration schedule is built around those fixed milligram steps, not units.

So if you are on brand tirzepatide and someone tells you a number of "units," something is wrong: that is not how the approved product works.

"Units" come from insulin syringes — and they measure volume, not drug

The word "units" on a U-100 insulin syringe is borrowed from insulin dosing. On those syringes, 100 units = 1 mL, so 1 unit = 0.01 mL. A unit is a measure of volume, not a measure of how much tirzepatide you are getting.

That distinction is the whole problem. How much tirzepatide sits in 1 mL — the concentration, written in mg/mL — is set by the compounding pharmacy, and it is not standardized across pharmacies or even across vials⁴. Two vials labeled "tirzepatide" can hold very different strengths. So the only way to turn 2.5 mg into units is to know your vial's exact concentration, and then do the math.

The conversion math (and why "it depends" is the real answer)

The formula is:

Volume to draw (mL) = dose in mg ÷ concentration in mg/mL Units = volume in mL × 100

Here is what 2.5 mg works out to at the concentrations compounding pharmacies commonly list. These are illustrations of the arithmetic, not a recommendation of any concentration or dose.

| Vial concentration | Volume for 2.5 mg | Units on a U-100 syringe | |--------------------|-------------------|--------------------------| | 5 mg/mL | 0.5 mL | 50 units | | 10 mg/mL | 0.25 mL | 25 units | | 20 mg/mL | 0.125 mL | 12.5 units | | 40 mg/mL | 0.0625 mL | ~6 units |

Look at the spread: the same 2.5 mg dose is anywhere from 6 to 50 units depending only on how concentrated the vial is. That is precisely why "how many units is 2.5 mg" has no fixed answer — and why memorizing a units number instead of checking your vial's concentration is a setup for an error. If you draw "50 units" out of a 40 mg/mL vial thinking you're getting 2.5 mg, you've actually drawn 20 mg — an eight-fold overdose.

This is not a theoretical risk

A case series reported to a U.S. poison control center documented exactly these mistakes with compounded GLP-1 medicine: patients confused milliliters, units, and milligrams, used non-standard syringes, and in two cases self-administered ten-fold dosing errors, ending up with days of nausea, vomiting, and abdominal pain³. A broader pharmacovigilance analysis of compounded GLP-1 receptor agonists, drawing on the FDA Adverse Event Reporting System, found a signal of medication errors and adverse events tied to the compounded products that the standardized brand pens are designed to prevent⁴.

The reason the brand pen exists in the first place is to take this math off the patient. Clinical guidance on compounded semaglutide and tirzepatide stresses that the absence of a fixed-dose delivery device — and the resulting reliance on patient-drawn volumes — is a core safety gap of the compounded route⁵. The units question is the visible edge of that gap.

The compounded-vs-brand distinction that actually matters here

To be clear about the categories:

• •Brand tirzepatide (Zepbound, Mounjaro) — FDA-approved, made by Eli Lilly, dispensed as fixed-dose pens/vials in milligrams. No units, no conversion¹².
• •Compounded tirzepatide — made by a compounding pharmacy, sold as a multi-dose vial at a pharmacy-chosen concentration, drawn up by the patient in units. Not FDA-approved as a finished product, and the entity that most often drives the units question.

Compounded products are not held to the same finished-product manufacturing and labeling standards as the approved brands, which is the underlying reason concentrations vary and conversion errors happen⁴⁵. We cover the legality and safety of the compounded route in more depth in the tirzepatide evidence guide, and the labeled milligram schedule that the brands use in the tirzepatide dosage chart. For why 2.5 mg is only a starting rung — never a maintenance dose — see our tirzepatide dosing ladder and side effects breakdown.

What 2.5 mg actually is, dose-wise

Worth remembering while you're doing any of this math: 2.5 mg is the initiation dose only. In the pivotal SURMOUNT-1 obesity trial, the doses that produced meaningful weight loss were the 5, 10, and 15 mg maintenance steps — 2.5 mg is the run-in week the body uses to adjust before stepping up⁶. A systematic review across the trial program found gastrointestinal side effects are dose-dependent and worst during increases, which is exactly why the schedule starts low and climbs slowly⁷. So a units error that turns a 2.5 mg starting dose into a much larger one doesn't just overshoot a number — it skips the entire tolerability ramp the drug is designed around⁶.

The honest bottom line

There is no single "units" answer for 2.5 mg of tirzepatide, and treating it like there is one is how overdoses happen. The FDA-approved brands aren't measured in units at all — they're fixed-dose pens and vials in milligrams¹². The units question belongs only to compounded vials, where the answer ranges from about 6 to 50 units for the very same 2.5 mg depending entirely on the vial's concentration⁴. If you are using a compounded product, the only safe number is the one calculated from your vial's exact mg/mL by the prescriber or pharmacist who supplied it — not a figure from a chart or a forum, given that real patients have hit ten-fold overdoses doing this conversion themselves³. To weigh the brand-versus-compounded decision and how to get the medicine safely, start with our best tirzepatide overview.